Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Datexim

Datexim
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$354K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of medical imaging technologies designed to detect diseases. The company's medical imaging products enable pathology laboratories to detect diseases quickly and accurately.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 51 Avenue de la Cote de Nacre
  • 14000 Caen
  • France

+33 02 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Datexim’s full profile, request a free trial.

Datexim Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC $354K 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Datexim Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Normandie Participations Venture Capital Minority 000 0000 000000 0

Datexim Executive Team (5)

Name Title Board
Seat
Contact
Info
Arnaud Renouf Ph.D Co-Founder & President
Jean-Hugues Pruvot Ph.D President & Manager, Research & Development
Cyril Bazin Ph.D Chief Technology Officer
David Lelouvier Advisor

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »